title: Is intermittent oral calcitriol safe and effective in renal secondary hyperparathyroidism?
authors.forename: G
authors.initials: G
authors.lastname: Klaus
authors.forename: O
authors.initials: O
authors.lastname: Mehls
authors.forename: J
authors.initials: J
authors.lastname: Hinderer
authors.forename: E
authors.initials: E
authors.lastname: Ritz
mesh_terms: D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D002117:Calcitriol / Q000008:administration & dosage* / Q000009:adverse effects; D002648:Child; D002675:Child, Preschool; D004334:Drug Administration Schedule; D004341:Drug Evaluation; D006801:Humans; D006961:Hyperparathyroidism / Q000188:drug therapy* / Q000209:etiology; D007676:Kidney Failure, Chronic / Q000150:complications*; D010281:Parathyroid Hormone / Q000097:blood
chemical_list: D010281:Parathyroid Hormone; D002117:Calcitriol